Search Within

Alexander Paul Boardman

Formats
  1. Meeting Abstract (15)
  2. Journal Article (9)
  3. Conference Paper (1)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (27)
  2. GME, Medicine (27)
  3. Graduate Medical Education (27)
  4. Hematology-Oncology Fellows (27)
  5. Hematologic Malignancies, Division of (26)
  6. Center for Hematologic Malignancies (25)

More Groups

People
  1. Gilles Salles (19)
  2. Maria Palomba (19)
  3. Lorenzo Falchi (12)
  4. Paola Ghione (11)
  5. Santosha Vardhana (11)
  6. Alison Moskowitz (9)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (9)
  4. 2022 (2)
Publications
  1. Blood (13)
  2. Blood Advances (2)
  3. International Journal of Radiation Oncology, Biology, Physics (2)
  4. Journal of Clinical Oncology (2)
  5. Blood Cancer Journal (1)
  6. Cancer Drug Discovery and Development (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Elsevier Inc. (3)
  3. American Society of Clinical Oncology (2)
  4. Nature Publishing Group (2)
  5. American Association for Cancer Research (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Targeting CD47 in lymphoid malignancies with CAR T cells
    Meeting Abstract

    Boardman, A. P.; James, S.; Van Den Brink, M. R. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • CAR T-cell therapy in large B cell lymphoma
    Conference Paper

    Boardman, A. P.; Salles, G.
    Wiley Blackwell (2023)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury in large cell lymphoma patients receiving CD19 CAR T cell therapy
    Meeting Abstract

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Tomas, A. A.; Fein, J. A.; Slingerland, J.; Parascondola, A.; Lin, R. J.; Scordo, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Biology of CAR-T cells
    Journal Article

    Berger, T. R.; Boardman, A.; Brentjens, R.; Maus, M. V.
    Cancer Drug Discovery and Development (2022)

    Fulltext@MSK | Save